Collagen
Product No. AG005K · Size: 3x0.5 mL (1 mg/ml)
Aggregation 
Description
Investigation of platelet aggregation induced by collagen.
Intended use
Investigation of congenital (e.g., Glanzmann’s thrombasthenia, gray platelet syndrome, storage pool disease) or acquired thrombopathy (e.g., myelodisplasic or myeloproliferative syndrome, Waldenström’s disease, multiple myeloma).
Follow-up of patients treated with antiplatelet drugs such as aspirin, thienopyridines, abciximab and other NSAIDs and GPIIb/IIIa inhibitors.
Related Products
Name
Insert
MSDS